Exelon (EXC) Stock Forecast & Price Target

$46.60 -0.30 (-0.64%)

Closing price 05/1/2025 04:00 PM Eastern

Extended Trading

$46.81 +0.21 (+0.45%)

As of 05/1/2025 07:48 PM Eastern

Exelon - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 9 Analyst Ratings

Sell
0

Hold
5

Buy
4

Based on 9 Wall Street analysts who have issued ratings for Exelon in the last 12 months, the stock has a consensus rating of "Hold." Out of the 9 analysts, 5 have given a hold rating, and 4 have given a buy rating for EXC.

Consensus Price Target

$46.67
0.14% Upside

According to the 9 analysts' twelve-month price targets for Exelon, the average price target is $46.67. The highest price target for EXC is $50.00, while the lowest price target for EXC is $42.00. The average price target represents a forecasted upside of 0.14% from the current price of $46.60.

Get the Latest News and Ratings for EXC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Exelon and its competitors.

EXC Analyst Ratings Over Time

Type	Current Forecast 5/2/24 to 5/2/25	1 Month Ago 4/2/24 to 4/2/25	3 Months Ago 2/2/24 to 2/1/25	1 Year Ago 5/3/23 to 5/2/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)	2 Buy rating(s)
Hold	5 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	10 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$46.67	$45.13	$43.13	$38.92
Forecasted Upside	0.14% Upside	-1.84% Downside	7.81% Upside	2.71% Upside
Consensus Rating	Hold	Moderate Buy	Moderate Buy	Hold

EXC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EXC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Exelon Stock vs. The Competition

Type	Exelon	Utilities Companies	S&P 500
Consensus Rating Score	2.44	2.50	2.54
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	0.14% Upside	19.23% Upside	19.83% Upside
News Sentiment Rating	Positive News See Recent EXC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/28/2025	BMO Capital Markets 4 of 5 stars	James Thalacker Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$46.00 ➝ $50.00	+7.51%
4/22/2025	Guggenheim 2 of 5 stars	S. Pourreza Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target	Buy ➝ Buy	$47.00	+1.45%
4/15/2025	Evercore ISI 2 of 5 stars	D. Chopra Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ In-Line	$46.00 ➝ $48.00	+2.43%
3/21/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Ford Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$45.00 ➝ $47.00	+6.52%
3/20/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Arcaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Equal Weight ➝ Equal Weight	$46.00 ➝ $48.00	+8.17%
2/25/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nicholas Campanella Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$42.00 ➝ $48.00	+10.73%
2/13/2025	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Weisel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Sector Perform ➝ Sector Perform	$42.00 ➝ $44.00	+2.00%
9/19/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$46.00	+17.08%
8/2/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$40.00 ➝ $42.00	+9.12%
1/19/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$38.00 ➝ $36.00	+2.53%
Get the Latest News and Ratings for EXC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Exelon and its competitors with MarketBeat's FREE daily newsletter.
1/10/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$36.00 ➝ $39.00	+7.03%
1/8/2024	Seaport Res Ptn Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Storozynski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
12/19/2023	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Sector Perform ➝ Sector Perform	$45.00 ➝ $38.00	+9.16%
12/18/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Neutral	$41.00	+18.09%
6/7/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Sell	$39.00	-3.32%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 01:04 AM ET.

Should I Buy Exelon Stock? EXC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, April 24, 2025. Please send any questions or comments about these Exelon pros and cons to contact@marketbeat.com.

Exelon
Bull Case

Here are some ways that investors could benefit from investing in Exelon Co.:

Exelon Co. recently reported earnings per share (EPS) of $0.64, exceeding analysts' expectations, which indicates strong financial performance and potential for growth.
The company has increased its quarterly dividend to $0.40 per share, reflecting a commitment to returning value to shareholders. This translates to an annualized dividend of $1.60, providing a yield of approximately 3.45%.
Exelon Co. has a solid return on equity of 9.52%, suggesting effective management and profitability relative to shareholder equity.
The current stock price is around $46.34, which is near its 12-month high of $48.11, indicating positive market sentiment and potential for further appreciation.
Analysts have a consensus rating of "Hold" with several firms issuing price targets above the current stock price, suggesting that there may be room for growth in the stock value.

Exelon
Bear Case

Investors should be bearish about investing in Exelon Co. for these reasons:

The company has a relatively high debt-to-equity ratio of 1.61, which may indicate higher financial risk and potential challenges in managing debt levels.
Exelon Co. has a current ratio of 0.87, suggesting that it may face liquidity issues in meeting short-term obligations, which could be a concern for investors.
Despite the recent increase in dividends, the dividend payout ratio stands at 65.31%, which may limit the company's ability to reinvest in growth opportunities.
Market volatility has affected stock performance, with the stock trading down about 1% recently, which could signal investor uncertainty.
While analysts have rated the stock with a mix of hold and buy ratings, the overall consensus remains cautious, indicating that some investors may be hesitant to commit to the stock at this time.

EXC Forecast - Frequently Asked Questions

: According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Exelon is $46.67, with a high forecast of $50.00 and a low forecast of $42.00.
: 9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Exelon in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" EXC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXC, but not buy additional shares or sell existing shares.
: According to analysts, Exelon's stock has a predicted upside of 0.14% based on their 12-month stock forecasts.
: Exelon has been rated by research analysts at Barclays, BMO Capital Markets, Evercore ISI, Guggenheim, Morgan Stanley, Scotiabank, and UBS Group in the past 90 days.
: Analysts like Exelon less than other "utilities" companies. The consensus rating for Exelon is Hold while the average consensus rating for "utilities" companies is Moderate Buy. Learn more on how EXC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NASDAQ:EXC) was last updated on 5/2/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Exelon (EXC) Stock Forecast & Price Target